Woman Needing Life-Saving Transplant Told to Move to Australia

A television special produced by TVNZ, titled You, Me and Aussie, has highlighted the desperate medical journey of Nicole Birch, a New Zealand woman battling end-stage kidney disease. As reported by 1News on May 12, 2026, Birch shared her struggle to find a life-saving kidney transplant within the New Zealand healthcare system.

Birch revealed during the program that her medical condition is complicated by very high antibodies, which significantly limits her options for a successful transplant. According to the reporting, Birch has a 4% chance of finding a match in New Zealand.

I have very high antibodies and I’ve been told, with a deceased donor, that my chance of receiving a donation here in New Zealand would be pretty much zero

Nicole Birch

Due to these stark odds, Birch has been advised by medical professionals in both New Zealand and Brisbane to relocate to Australia. The recommendation is based on the belief that Australia’s more diverse ethnic mix increases the probability of finding a compatible donor match.

Birch stated that every single medical professional she has consulted has urged her to make the move to save her life. While New Zealanders who can prove residence in Australia are eligible for public healthcare, the transition involves significant personal sacrifice.

The emotional and physical toll of the relocation was a central theme of her appearance on the TVNZ special. Birch described the move as a huge upheaval, noting that she must pack up 32 years of belongings to seek treatment abroad.

Beyond the logistics, Birch expressed deep concern over the impact on her family and pets. She identified the primary drawbacks as missing her children and the distress of potentially having to rehome her pets.

The program also examined the broader systemic differences between the healthcare landscapes of the two nations. Gabrielle McDonald, a public health physician at the University of Otago, provided insight into the varying availability and costs of medications.

McDonald noted that Australia provides funding for a broader array of medications, specifically highlighting immunotherapy drugs and biologicals. This makes Australia a more viable option for patients with certain complex conditions, such as cancer.

However, McDonald pointed out that New Zealand remains more affordable for standard, everyday illnesses. In New Zealand, prescriptions funded by Pharmac typically carry a $5 fee.

In contrast, the cost of prescriptions in Australia is higher, though McDonald noted that prices have recently been reduced from $35 to $25. For patients requiring long-term medication, these ongoing costs can accumulate significantly.

The story presented in You, Me and Aussie underscores the critical intersection of ethnic diversity and organ transplant compatibility, illustrating the lengths to which patients must go when local medical options are exhausted.